Firms

Pivotal bioVenture Partners

Pivotal bioVenture Partners

pivotallifesciences.com

Pivotal bioVenture Partners is the US venture capital operation of Pivotal Life Sciences, established in 2017 and based in San Francisco with a Boston-area office. It invests in innovative therapeutics in North America and Europe, supporting company creation, private financing, IPOs and follow-on public-market financing. Current official biographies name Peter Bisgaard and Rob Hopfner as managing partners, Jeni Lee as a partner and Glenn Batchelder as a venture partner. Its portfolio includes neuroscience businesses such as Karuna Therapeutics and MapLight Therapeutics as well as other biotechnology companies. Fund I was announced in March 2017 at approximately USD300 million with backing from Nan Fung Group. Fund II closed on December 18, 2023 with USD389 million in commitments, bringing the partnership's aggregate commitments to USD689 million. The US operation is distinct from Pivotal bioVenture Partners China, Nan Fung Life Sciences and the broader Pivotal Life Sciences investment platform; the displayed wordmark is the official shared platform brand.

Founded
—
Type
Venture capital

Funds2

  • Pivotal bioVenture Partners Fund II$389M

    Second US venture fund, with USD389 million in capital commitments at its December 18, 2023 final close. Focuses on innovative therapeutics in North America and Europe, from company building through later financing. Its close brought the US partnership's aggregate commitments to USD689 million; the broader platform's over-USD2-billion AUM was a separate figure.

  • Pivotal bioVenture Partners Fund I$300M

    Inaugural US life sciences venture fund, announced March 16, 2017 with approximately USD300 million and backing from Nan Fung Group. The issuer headline and historical subsequent firm announcements use USD300 million; the initial release also says over USD300 million. This is the inaugural fund, distinct from aggregate commitments and the parent platform's assets under management.

Team

Operations and support

Glenn BatchelderGlenn BatchelderVenture Partner
Jeni LeeJeni LeePartner
Peter BisgaardPeter BisgaardManaging Partner
Rob HopfnerRob HopfnerManaging Partner

Co-investing

Investments